Francesco Fraioli

Francesco Fraioli

Auto-generated profile, based on publicly available information

Francesco Fraioli

Institute of Nuclear Medicine, University College London (UCL), London, UK

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 April 2017 in Nature
Verified
Journal Article
Open access
PDF file
TCThe TRACERx consortium
The TRACERx consortium
CAChristopher Abbosh
Christopher Abbosh
TCThe PEACE consortium
The PEACE consortium
ABAnd Nicolai J. Birkbak
And Nicolai J. Birkbak
GWGareth A. Wilson
Gareth A. Wilson
CSCharles Swanton
Charles Swanton
The early detection of relapse following primary surgery for non-small-cell lung cancer and the characterization of emerging subclones, which seed metastatic sites, might offer new therapeutic approaches for limiting tumour recurrence. The ability to track the evolutionary dynamics of early-stage lung cancer non-invasively in circulating tumour DNA (ctDNA) has not yet been demonstrated. Here we use a tumour-specific phylogenetic approach to profile the ctDNA of the first 100 TRACERx (Tracking Non-Small-Cell Lung Cancer Evolution Through Therapy (Rx)) study participants, including one patient who was also recruited to the PEACE (Posthumous Evaluation of Advanced Cancer Environment) post-mortem study. We identify independent predictors of ctDNA release and analyse the tumour-volume detection limit. Through blinded profiling of postoperative plasma, we observe evidence of adjuvant chemotherapy resistance and identify patients who are very likely to experience recurrence of their lung cancer. Finally, we show that phylogenetic ctDNA profiling tracks the subclonal nature of lung cancer relapse and metastasis, providing a new approach for ctDNA-driven therapeutic studies.

1 May 2004 in Radiology
Verified
Journal Article
Closed access
CCCarlo CATALANO
Carlo CATALANO
FFFrancesco Fraioli
Francesco Fraioli
ALAndrea Laghi
Andrea Laghi
ANAlessandro Napoli
Alessandro Napoli
MBMario Bezzi
Mario Bezzi
RPRoberto Passariello
Roberto Passariello
PURPOSE: To compare multi–detector row spiral computed tomographic (CT) angiography with digital subtraction angiography (DSA) in evaluation of the infrarenal aorta and lower-extremity arterial system. MATERIALS AND METHODS: Fifty patients with peripheral arterial occlusive disease were evaluated with multi–detector row CT angiography and DSA. Arteries depicted at CT angiography and DSA were graded separately for degree of stenosis as 23 anatomic segments (infrarenal aorta, right and left common iliac artery, internal iliac artery, external iliac artery, common femoral artery, superficial femoral artery, deep femoral artery, popliteal artery, anterior tibial artery, tibioperoneal trunk, posterior tibial artery, and peroneal artery). Grades included the following: 1, normal patency; 2, moderate (≤50%) stenosis; 3, focal severe (>50%) stenosis; 4, multiple severe stenoses; and 5, occlusion. Three readers independently interpreted the images, and statistical analysis was performed. The results of image inter...

1 May 2003 in American Journal of Roentgenology
Verified
Journal Article
Closed access
CCC. Catalano
C. Catalano
FFF. Fraioli
F. Fraioli
ALAndrea Laghi
Andrea Laghi
ANA. Napoli
A. Napoli
Federica PediconiFederica Pediconi
Federica Pediconi
RPR. Passariello
R. Passariello
OBJECTIVE. The purpose of our study was to evaluate the accuracy of multidetector CT (MDCT) using a high-resolution protocol in the preoperative assessment of patients with renal cell carcinoma who are possible candidates for nephron-sparing surgery.MATERIALS AND METHODS. Forty patients with suspected renal cell carcinoma underwent MDCT. Contrast-enhanced acquisitions were obtained during arterial, nephrographic, and urographic phases using a thin-slice protocol. One-millimeter-thick source images were evaluated by two observers on a dedicated workstation for the identification and characterization of the tumor, presence of a pseudocapsule or invasion of perirenal fat, involvement of adrenal glands or surrounding tissues, presence of satellite lesions within Gerota's fascia, infiltration of renal vein and inferior vena cava, involvement of lymph nodes, and presence of distant metastases. Imaging findings were compared with surgical specimens using criteria from the Robson and TNM classification systems.RE...

1 January 2016 in NeuroImage: Clinical
Verified
Journal Article
Open access
IGIlaria Boscolo Galazzo
Ilaria Boscolo Galazzo
MMMaria Vittoria Mattoli
Maria Vittoria Mattoli
FPFrancesca Benedetta Pizzini
Francesca Benedetta Pizzini
EVEnrico De Vita
Enrico De Vita
Anna BarnesAnna Barnes
Anna Barnes
FFFrancesco Fraioli
Francesco Fraioli
The major challenge in pre-surgical epileptic patient evaluation is the correct identification of the seizure onset area, especially in MR-negative patients. In this study, we aimed to: (1) assess the concordance between perfusion, from ASL, and metabolism, from (18)F-FDG, acquired simultaneously on PET/MR; (2) verify the utility of a statistical approach as supportive diagnostic tool for clinical readers. Secondarily, we compared (18)F-FDG PET data from the hybrid PET/MR system with those acquired with PET/CT, with the purpose of validate the reliability of (18)F-FDG PET/MR data. Twenty patients with refractory focal epilepsy, negative MR and a defined electro-clinical diagnosis underwent PET/MR, immediately followed by PET/CT. Standardized uptake value ratio (SUVr) and cerebral blood flow (CBF) maps were calculated for PET/CT-PET/MR and ASL, respectively. For all techniques, z-score of the asymmetry index (zAI) was applied for depicting significant Right/Left differences. SUVr and CBF images were firstly visually assessed by two neuroimaging readers, who then re-assessed them considering zAI for reaching a final diagnosis. High agreement between (18)F-FDG PET/MR and ASL was found, showing hypometabolism and hypoperfusion in the same hemisphere in 18/20 patients, while the remaining were normal. They were completely concordant in 14/18, concordant in at least one lobe in the remaining. zAI maps improved readers' confidence in 12/20 and 15/20 patients for (18)F-FDG PET/MR and ASL, respectively. (18)F-FDG PET/CT-PET/MR showed high agreement, especially when zAI was considered. The simultaneous metabolism-perfusion acquisition provides excellent concordance on focus lateralisation and good concordance on localisation, determining useful complementary information.

1 May 2011 in Radiology
Verified
Journal Article
Closed access
FFFrancesco Fraioli
Francesco Fraioli
MAMichele Anzidei
Michele Anzidei
Fulvio ZaccagnaFulvio Zaccagna
Fulvio Zaccagna
MMMaria Luisa Mennini
Maria Luisa Mennini
GSGoffredo Serra
Goffredo Serra
RPRoberto Passariello
Roberto Passariello
Our results suggest that perfusion CT may allow evaluation of lung cancer angiogenesis demonstrating alterations in vascularity following treatment; these data may provide additional information on treatment outcome. PurposeTo determine whether wide-volume perfusion computed tomography (CT) performed with a new generation scanner can allow evaluation of the effects of chemotherapy combined with antiangiogenetic treatment on the whole tumor mass in patients with locally advanced lung adenocarcinoma and to determine if changes in CT numbers correlate with the response to therapy as assessed by conventional response evaluation criteria in solid tumors (RECIST).Materials and MethodsForty-five patients with unresectable lung adenocarcinoma underwent perfusion CT before and 40 and 90 days after chemotherapy and antiangiogenetic treatment. RECIST measurements and calculations of blood flow, blood volume, time to peak, and permeability were performed by two independent blinded radiologists. Pearson correlation coefficient was used to assess the correlation between baseline CT numbers. Baseline and follow-up perfusion parameters of the neoplastic lesions were tested overall for statistically significant differences by using th...

17 October 2011 in European Respiratory Journal
Verified
Journal Article
Open access
PDF file
FVFederico Venuta
Federico Venuta
MAMarco Anile
Marco Anile
DDDaniele Diso
Daniele Diso
CCCarolina Carillo
Carolina Carillo
TGTiziano De Giacomo
Tiziano De Giacomo
GCGiorgio F. Coloni
Giorgio F. Coloni
Bronchoscopic lung volume reduction (BLVR) is a novel emphysema therapy. We evaluated long-term outcome in patients with heterogeneous emphysema undergoing BLVR with one-way valves.40 patients undergoing unilateral BLVR entered our study. Pre-operative mean forced expiratory volume in 1 s (FEV1) was 0.88 L·s−1(23%), total lung capacity was 7.45 L (121%), intrathoracic gas volume was 6 L (174%), residual volume (RV) was 5.2 L (232%), and the 6-min walk test (6MWT) was 286 m. All patients required supplemental oxygen; the Medical Research Council (MRC) dyspnoea score was 3.9. High-resolution computed tomography (HRCT) results were reviewed to assess the presence of interlobar fissures.33 patients had a follow-up of >12 months (median 32 months). 37.5% of the patients had visible interlobar fissures. 40% of the patients died during follow-up. Three patients were transplanted and one underwent lung volume reduction surgery. Supplemental oxygen, FEV1, RV, 6MWT and MRC score showed a statistically significant improvement (p≤0.0001, p=0.004, p=0.03, p=0.003 and p<0.0001, respectively). Patients with visible fissures had a functional advantage.BLVR is feasible and safe. Long-term sustained improvements can be achieved. HRCT-visible interlobar fissures are a favourable prognostic factor.